{
    "organizations": [],
    "uuid": "39a66a51fb264f82255d832f3f3256d200c2b46a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-updates-on-acquisition-idUSFWN1RQ0JV",
    "ord_in_thread": 0,
    "title": "BRIEF-Guangzhou Baiyunshan Pharmaceutical Updates On Acquisition",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings:\n* RECEIVED LETTER OF NO FURTHER REVIEW FROM ANTI-MONOPOLY BUREAU OF MINISTRY OF COMMERCE OF PRC\n* PROPOSED ACQUISITION NOT SUBJECT TO FURTHER REVIEW, CO MAY PROCEED WITH ACQUISITION FROM APRIL 9 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-13T21:06:00.000+03:00",
    "crawled": "2018-04-14T13:21:18.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "guangzhou",
        "baiyunshan",
        "pharmaceutical",
        "holding",
        "received",
        "letter",
        "review",
        "bureau",
        "ministry",
        "commerce",
        "prc",
        "proposed",
        "acquisition",
        "subject",
        "review",
        "co",
        "may",
        "proceed",
        "acquisition",
        "april",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}